Given that CD68+ and CD163+ macrophages represent distinct subsets with distinct staining profiles based on a number of pathological features, we next determine if these differences reflected different immunological profiles within the tumour by measuring the expression of the macrophage enzymes iNOS and arginase. This evidence concerns the gene CD163 and neoplasm.